Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Gly-tyr-lys-dtpa
2. Glycyl-tyrosyl-lysine-dtpa
3. Gyk-dtpa
1. Pendetide [inn]
2. Gyk-dtpa
3. 60c8d1c9uj
4. 148805-91-8
5. Unii-60c8d1c9uj
6. Pendetide [usan]
7. Schembl306050
8. Dtxsid60164112
9. Q1981622
10. Glycyl-l-tyrosyl-n6-[n-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-n-(carboxymethyl)glycyl]-l-lysine
11. L-lysine, Glycyl-l-tyrosyl-n6-[n-[2-[[2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino]ethyl]-n-(carboxymethyl)glycyl]-
| Molecular Weight | 741.7 g/mol |
|---|---|
| Molecular Formula | C31H47N7O14 |
| XLogP3 | -11 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 28 |
| Exact Mass | 741.31809920 g/mol |
| Monoisotopic Mass | 741.31809920 g/mol |
| Topological Polar Surface Area | 330 Ų |
| Heavy Atom Count | 52 |
| Formal Charge | 0 |
| Complexity | 1200 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
26
PharmaCompass offers a list of Capromab Pendetide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Capromab Pendetide manufacturer or Capromab Pendetide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Capromab Pendetide manufacturer or Capromab Pendetide supplier.
A PROSTASCINT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of PROSTASCINT, including repackagers and relabelers. The FDA regulates PROSTASCINT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. PROSTASCINT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A PROSTASCINT supplier is an individual or a company that provides PROSTASCINT active pharmaceutical ingredient (API) or PROSTASCINT finished formulations upon request. The PROSTASCINT suppliers may include PROSTASCINT API manufacturers, exporters, distributors and traders.
PROSTASCINT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of PROSTASCINT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right PROSTASCINT GMP manufacturer or PROSTASCINT GMP API supplier for your needs.
A PROSTASCINT CoA (Certificate of Analysis) is a formal document that attests to PROSTASCINT's compliance with PROSTASCINT specifications and serves as a tool for batch-level quality control.
PROSTASCINT CoA mostly includes findings from lab analyses of a specific batch. For each PROSTASCINT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
PROSTASCINT may be tested according to a variety of international standards, such as European Pharmacopoeia (PROSTASCINT EP), PROSTASCINT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (PROSTASCINT USP).
